PhoenixBio
6190.TPhoenixBio Co., Ltd. Price (6190.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
3,781,759
(11.3303)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
PhoenixBio Co., Ltd. provides contract study services for drug discovery and development primarily in Japan. The company uses PXB-mouse, a chimeric mouse with a humanized liver for use in drug development experiments; and in vitro studies using fresh human hepatocytes taken from PXB-cells. The chimeric mouse model with a humanized liver is used for in vivo studies in gene therapeutics, NASH/NAFLD drug development programs, anti-viral therapeutic tests, DMPK/toxicity studies, and custom transplantations. The company was founded in 2002 and is headquartere... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $318-809
- Market Cap 1.55B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Takashi Shimada
- IPO Date: March, 18, 2016
- Country: JP
- Currency: JPY
- Headquaters: No Data
- Employees: 70
- Revenue from each product or segment:
| Product or Segment | Value: | % - Total | Last 3Y: |
|---|
- Revenue by Region
| Product or Segment | Value: | % - Total | Last 3Y: |
|---|